These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21118921)

  • 21. Cardiac effects of co-artemether (artemether/lumefantrine) and mefloquine given alone or in combination to healthy volunteers.
    Bindschedler M; Lefèvre G; Ezzet F; Schaeffer N; Meyer I; Thomsen MS
    Eur J Clin Pharmacol; 2000 Aug; 56(5):375-81. PubMed ID: 11009045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy, safety and tolerability of artesunate-mefloquine in the treatment of uncomplicated Plasmodium falciparum malaria in four geographic zones of Nigeria.
    Agomo PU; Meremikwu MM; Watila IM; Omalu IJ; Odey FA; Oguche S; Ezeiru VI; Aina OO
    Malar J; 2008 Sep; 7():172. PubMed ID: 18782445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria.
    Reuter SE; Upton RN; Evans AM; Navaratnam V; Olliaro PL
    J Antimicrob Chemother; 2015 Mar; 70(3):868-76. PubMed ID: 25377567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereoselective pharmacokinetics of mefloquine in healthy Caucasians after multiple doses.
    Gimenez F; Pennie RA; Koren G; Crevoisier C; Wainer IW; Farinotti R
    J Pharm Sci; 1994 Jun; 83(6):824-7. PubMed ID: 9120814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.
    Krudsood S; Looareesuwan S; Tangpukdee N; Wilairatana P; Phumratanaprapin W; Leowattana W; Chalermrut K; Ramanathan S; Navaratnam V; Olliaro P; Vaillant M; Kiechel JR; Taylor WR
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3730-7. PubMed ID: 20547795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High dose artesunate in combination with mefloquine: pharmacovigilance in the Venezuelan Amazon.
    Metzger WG; Magris M; Vivas-Martínez S; Giron A; Brooms JD; Villalobos N; Cruz L; Peña Pimentel FN; Perez L; España R
    Trans R Soc Trop Med Hyg; 2012 Mar; 106(3):196-8. PubMed ID: 22153748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multifocal myoclonus associated with mefloquine chemoprophylaxis.
    Jiménez-Huete A; Gil-Nagel A; Franch O
    Clin Neuropharmacol; 2002; 25(5):243. PubMed ID: 12410053
    [No Abstract]   [Full Text] [Related]  

  • 28. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
    Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
    Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind studies with mefloquine alone and in combination with sulfadoxine-pyrimethamine in 120 adults and 120 children with falciparum malaria in Vietnam.
    Trinh KA; Nguyen VK; Arnold K; Vo VC; Nguyen NB; Kim T; Ladinsky J
    Trans R Soc Trop Med Hyg; 1990; 84(1):50-3. PubMed ID: 2189246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerability of prophylactic Lariam regimens.
    Boudreau E; Schuster B; Sanchez J; Novakowski W; Johnson R; Redmond D; Hanson R; Dausel L
    Trop Med Parasitol; 1993 Sep; 44(3):257-65. PubMed ID: 8256107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artesunate with mefloquine at various intervals for non-severe Plasmodium falciparum malaria.
    Hung le Q; de Vries PJ; Binh TQ; Giao PT; Nam NV; Holman R; Kager PA
    Am J Trop Med Hyg; 2004 Aug; 71(2):160-6. PubMed ID: 15306704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study.
    McCarthy JS; Yalkinoglu Ö; Odedra A; Webster R; Oeuvray C; Tappert A; Bezuidenhout D; Giddins MJ; Dhingra SK; Fidock DA; Marquart L; Webb L; Yin X; Khandelwal A; Bagchus WM
    Lancet Infect Dis; 2021 Dec; 21(12):1713-1724. PubMed ID: 34715032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial.
    Tine RC; Faye B; Sylla K; Ndiaye JL; Ndiaye M; Sow D; Lo AC; Abiola A; Ba MC; Gaye O
    Malar J; 2012 Dec; 11():416. PubMed ID: 23234606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects.
    Nasveld PE; Edstein MD; Reid M; Brennan L; Harris IE; Kitchener SJ; Leggat PA; Pickford P; Kerr C; Ohrt C; Prescott W;
    Antimicrob Agents Chemother; 2010 Feb; 54(2):792-8. PubMed ID: 19995933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial.
    González R; Desai M; Macete E; Ouma P; Kakolwa MA; Abdulla S; Aponte JJ; Bulo H; Kabanywanyi AM; Katana A; Maculuve S; Mayor A; Nhacolo A; Otieno K; Pahlavan G; Rupérez M; Sevene E; Slutsker L; Vala A; Williamsom J; Menéndez C
    PLoS Med; 2014 Sep; 11(9):e1001735. PubMed ID: 25247995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.
    Denoeud-Ndam L; Zannou DM; Fourcade C; Taron-Brocard C; Porcher R; Atadokpede F; Komongui DG; Dossou-Gbete L; Afangnihoun A; Ndam NT; Girard PM; Cot M
    J Acquir Immune Defic Syndr; 2014 Feb; 65(2):198-206. PubMed ID: 24220287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.
    Silachamroon U; Krudsood S; Thanachartwet W; Tangpukdee N; Leowattana W; Chalermrut K; Srivilairit S; Wilaiaratana P; Thimasarn K; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):591-6. PubMed ID: 16124422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biowaiver monographs for immediate release solid oral dosage forms: mefloquine hydrochloride.
    Strauch S; Jantratid E; Dressman JB; Junginger HE; Kopp S; Midha KK; Shah VP; Stavchansky S; Barends DM
    J Pharm Sci; 2011 Jan; 100(1):11-21. PubMed ID: 20602454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuropsychiatric symptoms caused by mefloquine (report of several cases)].
    Murai Z; Baran B; Tolna J; Szily E; Gazdag G
    Orv Hetil; 2005 Jan; 146(3):133-6. PubMed ID: 15693445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetics of mefloquine in patients with acute falciparum malaria.
    Simpson JA; Price R; ter Kuile F; Teja-Isavatharm P; Nosten F; Chongsuphajaisiddhi T; Looareesuwan S; Aarons L; White NJ
    Clin Pharmacol Ther; 1999 Nov; 66(5):472-84. PubMed ID: 10579474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.